Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1992 May;85(5):285–287. doi: 10.1177/014107689208500515

Progress with a recombinant whooping cough vaccine: a review.

W N Burnette 1, V L Mar 1, D W Whiteley 1, T D Bartley 1
PMCID: PMC1294608  PMID: 1433093

Full text

PDF
285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arciniega J. L., Shahin R. D., Burnette W. N., Bartley T. D., Whiteley D. W., Mar V. L., Burns D. L. Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin. Infect Immun. 1991 Oct;59(10):3407–3410. doi: 10.1128/iai.59.10.3407-3410.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartley T. D., Whiteley D. W., Mar V. L., Burns D. L., Burnette W. N. Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit. Proc Natl Acad Sci U S A. 1989 Nov;86(21):8353–8357. doi: 10.1073/pnas.86.21.8353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bass J. W., Stephenson S. R. The return of pertussis. Pediatr Infect Dis J. 1987 Feb;6(2):141–144. doi: 10.1097/00006454-198702000-00001. [DOI] [PubMed] [Google Scholar]
  4. Burnette W. N., Cieplak W., Mar V. L., Kaljot K. T., Sato H., Keith J. M. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. Science. 1988 Oct 7;242(4875):72–74. doi: 10.1126/science.2459776. [DOI] [PubMed] [Google Scholar]
  5. Burnette W. N. The advent of recombinant pertussis vaccines. Biotechnology (N Y) 1990 Nov;8(11):1002–1005. doi: 10.1038/nbt1190-1002. [DOI] [PubMed] [Google Scholar]
  6. Cherry J. D. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984 Feb;14(2):1–78. doi: 10.1016/0045-9380(84)90016-1. [DOI] [PubMed] [Google Scholar]
  7. Cieplak W., Burnette W. N., Mar V. L., Kaljot K. T., Morris C. F., Chen K. K., Sato H., Keith J. M. Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4667–4671. doi: 10.1073/pnas.85.13.4667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cieplak W., Jr, Locht C., Mar V. L., Burnette W. N., Keith J. M. Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+. Biochem J. 1990 Jun 15;268(3):547–551. doi: 10.1042/bj2680547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hewlett E. L., Sauer K. T., Myers G. A., Cowell J. L., Guerrant R. L. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun. 1983 Jun;40(3):1198–1203. doi: 10.1128/iai.40.3.1198-1203.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaslow H. R., Schlotterbeck J. D., Mar V. L., Burnette W. N. Alkylation of cysteine 41, but not cysteine 200, decreases the ADP-ribosyltransferase activity of the S1 subunit of pertussis toxin. J Biol Chem. 1989 Apr 15;264(11):6386–6390. [PubMed] [Google Scholar]
  11. Katada T., Tamura M., Ui M. The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein. Arch Biochem Biophys. 1983 Jul 1;224(1):290–298. doi: 10.1016/0003-9861(83)90212-6. [DOI] [PubMed] [Google Scholar]
  12. Kimura M., Kuno-Sakai H. Acellular pertussis vaccines and fatal infections. Lancet. 1988 Apr 16;1(8590):881–882. doi: 10.1016/s0140-6736(88)91626-1. [DOI] [PubMed] [Google Scholar]
  13. Lobet Y., Cieplak W., Jr, Smith S. G., Keith J. M. Effects of mutations on enzyme activity and immunoreactivity of the S1 subunit of pertussis toxin. Infect Immun. 1989 Nov;57(11):3660–3662. doi: 10.1128/iai.57.11.3660-3662.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Locht C., Barstad P. A., Coligan J. E., Mayer L., Munoz J. J., Smith S. G., Keith J. M. Molecular cloning of pertussis toxin genes. Nucleic Acids Res. 1986 Apr 25;14(8):3251–3261. doi: 10.1093/nar/14.8.3251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Locht C., Keith J. M. Pertussis toxin gene: nucleotide sequence and genetic organization. Science. 1986 Jun 6;232(4755):1258–1264. doi: 10.1126/science.3704651. [DOI] [PubMed] [Google Scholar]
  16. Olin P., Storsaeter J., Romanus V. The efficacy of acellular pertussis vaccine. JAMA. 1989 Jan 27;261(4):560–560. [PubMed] [Google Scholar]
  17. Pittman M. Neurotoxicity of Bordetella pertussis. Neurotoxicology. 1986 Summer;7(2):53–67. [PubMed] [Google Scholar]
  18. Pittman M. The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis. 1984 Sep-Oct;3(5):467–486. doi: 10.1097/00006454-198409000-00019. [DOI] [PubMed] [Google Scholar]
  19. Pizza M., Covacci A., Bartoloni A., Perugini M., Nencioni L., De Magistris M. T., Villa L., Nucci D., Manetti R., Bugnoli M. Mutants of pertussis toxin suitable for vaccine development. Science. 1989 Oct 27;246(4929):497–500. doi: 10.1126/science.2683073. [DOI] [PubMed] [Google Scholar]
  20. Podda A., Nencioni L., De Magistris M. T., Di Tommaso A., Bossù P., Nuti S., Pileri P., Peppoloni S., Bugnoli M., Ruggiero P. Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med. 1990 Sep 1;172(3):861–868. doi: 10.1084/jem.172.3.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Romanus V., Jonsell R., Bergquist S. O. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J. 1987 Apr;6(4):364–371. doi: 10.1097/00006454-198704000-00005. [DOI] [PubMed] [Google Scholar]
  22. Sato H., Ito A., Chiba J., Sato Y. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect Immun. 1984 Nov;46(2):422–428. doi: 10.1128/iai.46.2.422-428.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tamura M., Nogimori K., Murai S., Yajima M., Ito K., Katada T., Ui M., Ishii S. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry. 1982 Oct 26;21(22):5516–5522. doi: 10.1021/bi00265a021. [DOI] [PubMed] [Google Scholar]
  24. Tamura M., Nogimori K., Yajima M., Ase K., Ui M. A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J Biol Chem. 1983 Jun 10;258(11):6756–6761. [PubMed] [Google Scholar]
  25. Weiss A. A., Hewlett E. L. Virulence factors of Bordetella pertussis. Annu Rev Microbiol. 1986;40:661–686. doi: 10.1146/annurev.mi.40.100186.003305. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES